FBP1 and cancer: Previous studies have focused on catabolic glycolysis, but recent studies have found that FBP, acting as a rate-limiting enzyme that controls the conversion of fructose 1,6-diphosphate to fructose 6-phosphate, plays a key role in tumor initiation and progression in various cancers.